Shiseido logo

Shiseido

Last updated January 31, 2026
66
Innovation Areas
1,496
Inventors
12
Collaborations

Hyaluronic acid biosynthetic promoters: ShiseidoRecent Research Landscape

Inconsistent endogenous hyaluronic acid and collagen levels lead to visible tissue degradation, which is mitigated through the targeted application of astragaloside preparations. This specific chemical lever stabilizes the extracellular matrix to ensure predictable dermatological performance.

What technical problems is Shiseido addressing in Hyaluronic acid biosynthetic promoters?

Impaired epidermal barrier integrity

(17)evidences

Insufficient endogenous production of growth factors and structural lipids leads to skin fragility. Restoring these biological components prevents moisture loss and environmental damage.

Excessive cutaneous melanin accumulation

(15)evidences

Overactive sebaceous glands lead to skin oiliness and associated dermatological issues. Controlling this secretion improves skin health and aesthetic appearance.

Insufficient endogenous hyaluronic acid synthesis

(5)evidences

Natural cellular production levels of hyaluronic acid and essential vitamins are often inadequate for therapeutic or cosmetic efficacy. Addressing this metabolic limitation ensures consistent physiological performance and tissue hydration.